agilon health priced pricing its underwritten public offering of 17 million shares by certain selling stockholders at an offering price of $30 per share. The underwriters have a 30-day option to purchase up to an additional 2.55 million shares. agilon health will not receive any proceeds from the secondary offering., which is expected to close Sept. 14. Read more.
Related Posts
Vensana Capital Raises $325M
The Minneapolis-based med-tech VC firm raised $325 million for its second fund.
September 29, 2021
TPG Taps New President, Will Oversee Healthcare Investing
TPG named Todd Sisitsky as firm president, and said he'll continue to head healthcare investing.
September 24, 2021
Healthcare Venture Capital has Already Blown Away 2020 Records; Does It Have the Juice to Keep Growing?
With VC dollars flowing like never before, are there some cracks showing in biopharma’s gold-tinted façade?
July 22, 2021
Consonance Capital Partners Adds 4 to Advisory Board
The PE firm said it added four healthcare professionals to its operating council and senior advisory board.
October 20, 2021